RecruitingPhase 1 / Phase 2NCT07020221
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Sponsor: Verastem, Inc.
New York, NY · +12 more sites
Colorectal Cancer clinical trials in New York, NY
75 recruiting colorectal cancer studies with a site in New York, NY.
RecruitingPhase not listedNCT03432806
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +1 more sites
RecruitingPhase 1 / Phase 2NCT05786924
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Sponsor: Institut de Recherches Internationales Servier
New York, NY · +19 more sites
RecruitingNot applicableNCT06228209
Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
Sponsor: Icahn School of Medicine at Mount Sinai
New York, NY
RecruitingPhase 1NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Sponsor: Astellas Pharma Inc
Buffalo, NY · New York, NY · +9 more sites
RecruitingPhase 3NCT07222800
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Sponsor: Pfizer
Albany, NY · Auburn, NY · Babylon, NY · +251 more sites
RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
New York, NY · +30 more sites
RecruitingPhase 1NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Sponsor: Eli Lilly and Company
Mineola, NY · New York, NY · +8 more sites
RecruitingPhase 1 / Phase 2NCT06710756
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Sponsor: Perspective Therapeutics
New York, NY · +15 more sites
RecruitingPhase 3NCT06997497
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Sponsor: Merck Sharp & Dohme LLC
New York, NY · Schenectady, NY · +46 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
New York, NY · +14 more sites
RecruitingPhase 1NCT04429542
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Sponsor: Bicara Therapeutics
New York, NY · +13 more sites
RecruitingPhase 1 / Phase 2NCT06428409
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Sponsor: Merck Sharp & Dohme LLC
Mineola, NY · New York, NY · +11 more sites
RecruitingPhase 3NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor: Summit Therapeutics
Mineola, NY · New York, NY · Rochester, NY · +109 more sites
RecruitingNot applicableNCT04751435
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Sponsor: Memorial Sloan Kettering Cancer Center
Brooklyn, NY · Jamaica, NY · New York, NY · +1 more sites
RecruitingNot applicableNCT06037954
A Study of Mental Health Care in People With Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
New York, NY
RecruitingPhase 1NCT07454642
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Sponsor: Avacta Life Sciences Ltd
New York, NY · +6 more sites
RecruitingNot applicableNCT05612347
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Sponsor: Dartmouth-Hitchcock Medical Center
New York, NY · +19 more sites
RecruitingPhase 2NCT05673148
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Sponsor: Alliance for Clinical Trials in Oncology
Brooklyn, NY · Commack, NY · Flushing, NY · +185 more sites
RecruitingPhase 1NCT05877599
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Sponsor: AstraZeneca
New York, NY · +19 more sites
RecruitingPhase 1NCT06218914
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Sponsor: AstraZeneca
New York, NY · +16 more sites
RecruitingPhase 3NCT05863195
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Sponsor: ECOG-ACRIN Cancer Research Group
Buffalo, NY · Commack, NY · East White Plains, NY · +59 more sites
RecruitingPhase 1 / Phase 2NCT06445062
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Sponsor: Revolution Medicines, Inc.
Lake Success, NY · New York, NY · +29 more sites
RecruitingPhase 2NCT07227636
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
Sponsor: Memorial Sloan Kettering Cancer Center
Commack, NY · Harrison, NY · New York, NY · +4 more sites
RecruitingPhase 1 / Phase 2NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Sponsor: Eikon Therapeutics
Lake Success, NY · New York, NY · +8 more sites
RecruitingNot applicableNCT07623902
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
Sponsor: Jubaan Ltd.
Carmel, NY · New York, NY · +6 more sites
RecruitingPhase 1 / Phase 2NCT07629960
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Sponsor: Blueprint Medicines Corporation
New York, NY · +9 more sites
RecruitingPhase 1NCT07020117
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Sponsor: Aktis Oncology, Inc.
New York, NY · +12 more sites
RecruitingPhase 1NCT07217171
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Sponsor: EvolveImmune United, Inc
New York, NY · +13 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
New York, NY · +32 more sites
RecruitingNot applicableNCT07391956
Tier Palliative Care For Patients With Advanced Heart Failure or Cancer
Sponsor: Icahn School of Medicine at Mount Sinai
Astoria, NY · New York, NY · +2 more sites
RecruitingPhase 1 / Phase 2NCT04851119
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Sponsor: Children's Oncology Group
New York, NY · +20 more sites
RecruitingPhase 1NCT06586515
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Sponsor: Eli Lilly and Company
New York, NY · +23 more sites
RecruitingPhase 1 / Phase 2NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Sponsor: Bristol-Myers Squibb
New York, NY · +9 more sites
RecruitingPhase 1 / Phase 2NCT07277322
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
Sponsor: Dan Feng
New York, NY
RecruitingPhase not listedNCT06880055
Shield Post-Approval Study Protocol
Sponsor: Guardant Health, Inc.
Camillus, NY · East Syracuse, NY · Fayetteville, NY · +66 more sites
RecruitingPhase 1 / Phase 2NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Sponsor: Daiichi Sankyo
New York, NY · Westbury, NY · +15 more sites
RecruitingPhase 1NCT05433142
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Sponsor: Xencor, Inc.
New York, NY · +18 more sites
RecruitingPhase not listedNCT06096688
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Sponsor: Weill Medical College of Cornell University
New York, NY
RecruitingNot applicableNCT07225309
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
New York, NY
RecruitingPhase 1 / Phase 2NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Sponsor: Merus B.V.
Ithaca, NY · New York, NY · +28 more sites
RecruitingPhase 1NCT06179160
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Sponsor: Incyte Corporation
New York, NY · +11 more sites
RecruitingPhase 1NCT07318805
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Sponsor: Pfizer
Long Island City, NY · New York, NY · +10 more sites
RecruitingPhase 1NCT06657144
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Sponsor: Coherus Oncology, Inc.
Lake Success, NY · New York, NY · +17 more sites
RecruitingPhase 2NCT06937177
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Sponsor: Endevica Bio
New York, NY · +24 more sites
RecruitingPhase 2NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Sponsor: Jazz Pharmaceuticals
New York, NY · +16 more sites
RecruitingPhase not listedNCT07649057
A Study of a Urine Test to Detect Colorectal Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
New York, NY
RecruitingPhase 1 / Phase 2NCT06051695
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Sponsor: A2 Biotherapeutics Inc.
New York, NY · +11 more sites
RecruitingPhase 1NCT06835569
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Sponsor: Alterome Therapeutics, Inc.
New York, NY · +10 more sites
RecruitingPhase 1 / Phase 2NCT03947385
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Sponsor: IDEAYA Biosciences
New York, NY · +11 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.